ALCL

Clinical trials for ALCL explained in plain language.

Never miss a new study

Get alerted when new ALCL trials appear

Sign up with your email to follow new studies for ALCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Cancer patients get lifeline: continued access to treatment after trial ends

Disease control Ongoing

This study provides continued access to crizotinib treatment for people with certain cancers who were already benefiting from the medication in previous Pfizer trials that are closing. It allows 27 eligible participants to keep receiving their treatment while researchers continue…

Matched conditions: ALCL

Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

ALCL

Get alerted when new ALCL trials appear

Cancer patients get lifeline: continued access to treatment after trial ends